Weiwei Xia
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Immunology top 5%
- interferon and immune responses
- Immune Response and Inflammation
Papers in
- Surgery 18
- Scoliosis diagnosis and treatment 6
- Spinal Fractures and Fixation Techniques 5
-
- Inflammasome and immune disorders 7
- Co-authors
- Zhanjun Jia (19 shared papers)Aihua Zhang (14 shared papers)Songming Huang (16 shared papers)Zhenqi Zhu (14 shared papers)Kaifeng Wang (15 shared papers)Yue Zhang (8 shared papers)Mengying Wu (7 shared papers)Jie Li (1 shared paper)
- Journals
- BMC Musculoskeletal Disorders (3 papers)PLoS ONE (3 papers)Oncotarget (2 papers)Cellular Physiology and Biochemistry (2 papers)Journal of Global Health (2 papers)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Weiwei Xia
69 papers receiving 1.6k citations
Weiwei Xia's Hit Papers
Peers
Comparison fields: 5 of 116
- Nephrology 147
- Immunology 404
- Pathology and Forensic Medicine 212
- Molecular Biology 571
- Cancer Research 115
Countries citing papers authored by Weiwei Xia
This map shows the geographic impact of Weiwei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Xia more than expected).
Fields of papers citing papers by Weiwei Xia
This network shows the impact of papers produced by Weiwei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Xia. The network helps show where Weiwei Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 300 | |
| 2 | Blood–Spinal Cord Barrier in Spinal Cord Injury: A Review Hit paper breakdown → | 2020 | 194 |
| 3 | 2021 | 132 | |
| 4 | 2005 | 111 | |
| 5 | 2014 | 85 | |
| 6 | 2015 | 84 | |
| 7 | 2019 | 54 | |
| 8 | 2019 | 51 | |
| 9 | 2018 | 48 | |
| 10 | 2011 | 40 | |
| 11 | 2020 | 38 | |
| 12 | 2014 | 37 | |
| 13 | 2016 | 29 | |
| 14 | 2020 | 29 | |
| 15 | Inhibition of COX-2/PGE2 cascade ameliorates cisplatin-induced mesangial cell apoptosis. | 2017 | 26 |
| 16 | 2018 | 25 | |
| 17 | 2022 | 23 | |
| 18 | 2016 | 19 | |
| 19 | 2018 | 17 | |
| 20 | 2022 | 17 |
About Weiwei Xia
Weiwei Xia is a scholar working on Surgery, Molecular Biology, Pathology and Forensic Medicine, Nephrology and Cancer Research, having authored 72 papers that have together received 1.6k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), Scoliosis diagnosis and treatment (6 papers), Spinal Fractures and Fixation Techniques (5 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Gout, Hyperuricemia, Uric Acid (3 papers), interferon and immune responses (3 papers), Spinal Cord Injury Research (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). The work is most often cited by research in Nephrology (147 citations), Immunology (404 citations), Pathology and Forensic Medicine (212 citations), Molecular Biology (571 citations) and Cancer Research (115 citations). Weiwei Xia has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Zhanjun Jia, Aihua Zhang, Songming Huang, Zhenqi Zhu, Kaifeng Wang, Yue Zhang, Mengying Wu, Jie Li, Jun Gu and Xin‐Feng Li. Their work appears in journals such as BMC Musculoskeletal Disorders, PLoS ONE, Oncotarget, Cellular Physiology and Biochemistry and Journal of Global Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.